» Articles » PMID: 2548843

Bovine Papilloma Virus Encoded E2 Protein Activates Lymphokine Genes Through DNA Elements, Distinct from the Consensus Motif, in the Long Control Region of Its Own Genome

Overview
Journal EMBO J
Date 1989 May 1
PMID 2548843
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of T cells by antigen, lectin or a combination of phorbol ester (PMA) and calcium ionophore (A23187) leads to the induction of a set of lymphokine genes. Transfection of a human T cell leukemia cell line, Jurkat, or an African green monkey kidney cell line, CV1, with a cDNA encoding E2 protein, a trans-activator of bovine papilloma virus type 1, results in activation of interleukin 2 (IL-2), interleukin 3 (IL-3) and granulocyte/macrophage colony-stimulating factor (GM-CSF) genes in a transient transfection assay. 5' deletion and mutation analyses showed that the sequence between positions -60 and a TATA-like sequence is required for basic promotor function and that the sequence between positions -95 and -73 containing conserved lymphokine element 2 (CLE2) and a GC box (CLE2/GC box) mediates the positive response to E2 protein. The latter has been previously shown to respond to PMA/A23187 stimulation or to p40tax, a trans-activator encoded by human T cell leukemia virus type 1 (HTLV-I). The sequence located between -108 and -99 (CLE1) is inhibitory to E2 protein or PMA/A23187 stimulation. The combination of E2 protein and PMA/A23187 appears to eliminate an inhibitory effect of the upstream region. However, E2 protein, like p40tax, mediates a positive response through CLE1 alone linked to the basic promoter sequence. The level of activation of the long control region (LCR) by E2 protein is unaffected by the number of CLE2/GC box sequences.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation.

Hadaschik D, Hinterkeuser K, Oldak M, Pfister H, Smola-Hess S J Virol. 2003; 77(9):5253-65.

PMID: 12692227 PMC: 153950. DOI: 10.1128/jvi.77.9.5253-5265.2003.


Cooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.

Muller A, Ritzkowsky A, Steger G J Virol. 2002; 76(21):11042-53.

PMID: 12368347 PMC: 136630. DOI: 10.1128/jvi.76.21.11042-11053.2002.


Mast cell tumor necrosis factor alpha production is regulated by MEK kinases.

Ishizuka T, Terada N, Gerwins P, Hamelmann E, Oshiba A, Fanger G Proc Natl Acad Sci U S A. 1997; 94(12):6358-63.

PMID: 9177222 PMC: 21054. DOI: 10.1073/pnas.94.12.6358.


Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.

Steger G, Corbach S J Virol. 1997; 71(1):50-8.

PMID: 8985322 PMC: 191023. DOI: 10.1128/JVI.71.1.50-58.1997.


Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication.

Ferguson M, Botchan M J Virol. 1996; 70(7):4193-9.

PMID: 8676438 PMC: 190348. DOI: 10.1128/JVI.70.7.4193-4199.1996.


References
1.
Kishimoto A, Takai Y, Mori T, Kikkawa U, NISHIZUKA Y . Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem. 1980; 255(6):2273-6. View

2.
Spalholz B, Lambert P, Yee C, Howley P . Bovine papillomavirus transcriptional regulation: localization of the E2-responsive elements of the long control region. J Virol. 1987; 61(7):2128-37. PMC: 254233. DOI: 10.1128/JVI.61.7.2128-2137.1987. View

3.
Lusky M, Botchan M . Characterization of the bovine papilloma virus plasmid maintenance sequences. Cell. 1984; 36(2):391-401. DOI: 10.1016/0092-8674(84)90232-0. View

4.
NISHIZUKA Y . The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984; 308(5961):693-8. DOI: 10.1038/308693a0. View

5.
Weiss A, Wiskocil R, Stobo J . The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol. 1984; 133(1):123-8. View